ferric chloride has been researched along with Arterial Diseases, Carotid in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Q; Fu, C; Li, B; Ma, G; Yao, Y | 1 |
| Adler, K; Borst, O; Brandl, R; Degen, H; Fassbender, J; Gawaz, M; Göbel, S; Jamasbi, J; Lorenz, R; Mojica Munoz, AK; Münch, G; Siess, W; Ungerer, M; Walker, B; Ziegler, M | 1 |
| Chen, CH; Fu, WM; Gau, SS; Hsu, CC; Huang, SW; Huang, TF; Liao, HM; Liou, HC; Lu, DH; Tu, HJ | 1 |
| Li, W; McIntyre, TM; Silverstein, RL; Srikanthan, S | 1 |
| Etscheid, M; Kanse, SM; Morowski, M; Nieswandt, B; Pragst, I; Sandset, PM; Subramaniam, S; Thielmann, I | 1 |
| Chauhan, AK; Dhanesha, N; Doddapattar, P; Khanna, I; Nayak, MK; Pollpeter, MJ; Prakash, P; Staber, JM | 1 |
| Dieudé, M; Gillis, MA; Lajoie, G; Levine, JS; Merhi, Y; Rauch, J; Théorêt, JF; Thorin, E | 1 |
| Møller, F; Tranholm, M | 1 |
| Baumgartner, B; Eder, B; Jaki, T; Muchitsch, EM; Schiviz, A; Schwarz, HP; Wolfsegger, MJ | 1 |
| Wang, X; Xu, L | 1 |
| Cheng, Q; Feuerstein, GZ; Gailani, D; Hsu, MY; Ogletree, ML; Schumacher, WA; Seiffert, DA; Smith, PL; Wang, X; Xu, L | 1 |
| Dellas, C; Hasenfuss, G; Konstantinides, SV; Nitsche, M; Puls, M; Schäfer, K; Schroeter, MR; Weiss, E | 1 |
| Ahrens, I; Bassler, N; Bode, C; Chen, YC; Fitzgerald, D; Hagemeyer, CE; Kenny, D; Meade, G; Moran, N; Peter, K; Schwarz, M; Stoll, P; Ylanne, J | 1 |
| Bird, E; Hsu, MY; Schumacher, WA; Smith, PL; Tamasi, JA; Wang, X | 1 |
| Berges, A; Humboldt, T; Konstantinides, S; Lebrun, S; Leifheit, M; Meurrens, K; Sawalich, M; Schaefer, K; Schleef, R; Schroeter, MR; Wallerath, T; Xu, H | 1 |
| Kambayashi, J; Lockyer, S | 1 |
16 other study(ies) available for ferric chloride and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Photoacoustic Imaging: A Novel Tool for Detecting Carotid Artery Thrombosis in Mice.
Topics: Animals; Biopsy; Carotid Artery Diseases; Carotid Artery, Common; Chlorides; Disease Models, Animal; Ferric Compounds; Male; Mice, Inbred ICR; Photoacoustic Techniques; Predictive Value of Tests; Thrombosis; Time Factors; Ultrasonography, Doppler, Color | 2017 |
ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Topics: Animals; Antigens, CD; Apyrase; Carotid Artery Diseases; Carotid Artery Injuries; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ferric Compounds; Fibrinolytic Agents; Glycoproteins; Hemorrhage; Humans; Immunoglobulin Fc Fragments; Male; Mice, Inbred C57BL; Plaque, Atherosclerotic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Recombinant Fusion Proteins; Thrombosis | 2017 |
ARHGEF10 knockout inhibits platelet aggregation and protects mice from thrombus formation.
Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Carotid Artery Diseases; Cell Shape; Chlorides; Disease Models, Animal; Ferric Compounds; Gene Knockout Techniques; Genotype; Hemostasis; Male; Mice, 129 Strain; Mice, Knockout; Myosin Light Chains; Phenotype; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Rho Guanine Nucleotide Exchange Factors; Selenoprotein P; Thrombosis; Time Factors | 2017 |
Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions.
Topics: Animals; Blood Platelets; Carotid Artery Diseases; CD36 Antigens; Cell-Derived Microparticles; Chlorides; Cholesterol; Collagen; Disease Models, Animal; Exosomes; Ferric Compounds; Foam Cells; Humans; Lipoproteins, LDL; Mice, Inbred C57BL; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Transfusion; Polyubiquitin; Proteasome Endopeptidase Complex; Proteolysis; Signal Transduction; Thrombocytopenia; Thrombosis; Time Factors; Ubiquitination | 2014 |
Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP).
Topics: Animals; Blood Coagulation Tests; Carotid Arteries; Carotid Artery Diseases; Chlorides; Collagen; Disease Models, Animal; Ferric Compounds; Genetic Predisposition to Disease; Hemostasis; Jugular Veins; Lipoproteins; Mesenteric Arteries; Mesenteric Vascular Occlusion; Mice, Inbred C57BL; Mice, Knockout; Norepinephrine; Phenotype; Serine Endopeptidases; Thrombosis; Venous Thromboembolism | 2015 |
Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Topics: ADAMTS13 Protein; Animals; Blood Platelets; Bone Marrow Transplantation; Carotid Artery Diseases; Chlorides; Disease Models, Animal; Endothelial Cells; Ferric Compounds; Genetic Predisposition to Disease; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Lasers; Male; Mesenteric Vascular Occlusion; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Phenotype; Platelet Transfusion; Reperfusion Injury; Signal Transduction; Thrombosis; Time Factors; von Willebrand Factor | 2016 |
Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis.
Topics: Animals; Arterial Occlusive Diseases; Autoantibodies; Carotid Artery Diseases; Chaperonin 60; Chlorides; Disease Models, Animal; Ferric Compounds; Mice; P-Selectin; Regional Blood Flow; Reperfusion; Thrombosis; von Willebrand Factor | 2009 |
A ferric chloride induced arterial injury model used as haemostatic effect model.
Topics: Animals; Carotid Artery Diseases; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Factor IX; Factor VIII; Ferric Compounds; Hemophilia A; Hemostasis; Mice; Mice, Knockout; Recombinant Proteins; Thrombosis | 2010 |
Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia A.
Topics: Animal Use Alternatives; Animal Welfare; Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Chlorides; Coagulants; Disease Models, Animal; Female; Ferric Compounds; Hemophilia A; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Regional Blood Flow; Research Design | 2010 |
An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research.
Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Chlorides; Clopidogrel; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Heparin; Kinetics; Mice; Regional Blood Flow; Research; Thrombosis; Ticlopidine | 2005 |
Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice.
Topics: Animals; Arteries; Aspirin; Bleeding Time; Blood Flow Velocity; Carotid Arteries; Carotid Artery Diseases; Chlorides; Dose-Response Relationship, Drug; Factor IX; Factor XI; Factor XI Deficiency; Ferric Compounds; Genotype; Hemophilia B; Heparin; Homozygote; Mice; Mice, Inbred C57BL; Platelet Aggregation; Regional Blood Flow; Thrombosis; Time Factors | 2005 |
Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carotid Arteries; Carotid Artery Diseases; Carotid Stenosis; Cell Differentiation; Chlorides; DNA; Female; Ferric Compounds; Macrophages; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Plasminogen Activator Inhibitor 1; Thrombosis; Time Factors; Tunica Intima; Y Chromosome | 2006 |
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Topics: Amino Acid Motifs; Animals; Antibodies; Bleeding Time; Blood Platelets; Carotid Artery Diseases; Chlorides; Complementarity Determining Regions; Eptifibatide; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Humans; Mice; Mice, Inbred C57BL; Molecular Conformation; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 2006 |
Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis.
Topics: Animals; Bleeding Time; Carboxypeptidase B2; Carotid Artery Diseases; Chlorides; Coagulants; Disease Models, Animal; Female; Ferric Compounds; Male; Mice; Mice, Knockout; Plant Proteins; Protease Inhibitors; Thrombelastography; Venae Cavae; Venous Thrombosis | 2007 |
Cigarette smoke exposure promotes arterial thrombosis and vessel remodeling after vascular injury in apolipoprotein E-deficient mice.
Topics: Actins; Animals; Apolipoproteins E; Apoptosis; Carotid Artery Diseases; Cell Proliferation; Cells, Cultured; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Humans; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Smoke; Smoking; Thrombosis; Time Factors; Vascular Patency | 2008 |
Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis.
Topics: Animals; Antifibrinolytic Agents; Antithrombins; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Carotid Artery Diseases; Carotid Artery, Common; Chlorides; Ferric Compounds; Fibrinolytic Agents; Heparin; Hirudins; Immune Sera; Ligation; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Thrombosis; Tranexamic Acid | 1999 |